Serologic markers in inflammatory bowel disease.
Inflammatory bowel disease (IBD) is an enduring disease involving mostly young people, with symptoms of bloody diarrhea and abdominal cramps. Several antibodies have been associated with IBD, the 2 most comprehensively studied being autoantibodies to neutrophils (atypical perinuclear anti-neutrophil cytoplasmic antibodies) and anti-Saccharomyces cerevisiae antibodies. This review focuses on the value of these antibodies for diagnosing IBD, differentiating Crohn disease from ulcerative colitis, indeterminate colitis, monitoring disease, defining clinical phenotypes, predicting response to therapy, and as subclinical markers. Pancreatic antibodies and newly identified anti-microbial antibodies (anti-outer membrane porin C, anti-I2, and anti-flagellin) are also reviewed.
Bossuyt
Xavier
X
Laboratory Medicine, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Xavier.Bossuyt@uz.kuleuven.ac.be
D000907:Antibodies, Bacterial / Q000097:blood; D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003093:Colitis, Ulcerative / Q000097:blood / Q000175:diagnosis; D003424:Crohn Disease / Q000097:blood / Q000175:diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000175:diagnosis*; D009504:Neutrophils / Q000276:immunology; D010179:Pancreas / Q000276:immunology; D012441:Saccharomyces cerevisiae / Q000276:immunology; D012698:Serologic Tests
D000907:Antibodies, Bacterial; D001323:Autoantibodies; D015415:Biomarkers